ARCHIVES

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Roswell Park, Karmanos Read The Cancer Letter Interactive.

December 1, 2000

Assurances On Methods For Misconduct Reporting Required

December 1, 1989

In Brief: Broder Keynote Speaker At ACCC Meeting; Tefft To Head Radiation Therapy At Cleveland Clinic

February 24, 1989

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991